Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Directorate Change

16 Sep 2013 07:03

RNS Number : 0218O
Plant Health Care PLC
16 September 2013
 



Plant Health Care PLC

 

16 September 2013

 

PLANT HEALTH CARE PLC

 

("Plant Health Care" or "the Company")

 

Directorship Changes

 

Plant Health Care appoints Dr Richard Webb as non-executive director

 

Resignation of John Brady and release from obligation to exercise options

 

The Board of Plant Health Care is pleased to announce the appointment ofRichard Webb as a non-executive director.

 

Dr Webb, age 54, has previously been engaged by the Group as a consultant, and was instrumental in the development of its new business strategy and its current research and development strategy.

 

Dr Webb is Director of StepOut Ltd, a consultancy business he founded in 1995. Prior to that, he held various posts in the former ICI, including a period managing laboratory discovery and field development programmes for its public health business. He has had particularly broad exposure to the international agrochemical industry, which he has advised across a full spectrum of activities, from research targeting to post-patent brand management.

 

Dr Webb has a personal holding of 10,000 shares in the Company (representing 0.01% of the current issued share capital).

 

Dr Christopher Richards, Chairman, commented: "Richard Webb brings many years of strategic and innovation consulting experience to the Company and will specifically reinforce the science discussions at the Board."

 

Save for the information disclosed above, there is no other information to be disclosed under Rule 17 or Schedule Two, paragraph (g) of the AIM Rules for Companies in relation to Dr Richard Hannam Webb's appointment as a Director of the Company, other than as follows:

 

Current Directorships Past Directorships:

 

StepOut Ltd None

 

Investors in Innovation Ltd

 

Resignation of John Brady and release from obligation to exercise options

 

Further to an announcement made on 15 July 2013, the Company confirms that Mr John Brady, whose resignation as a director is effective as of today, shall be released from his obligation to exercise his options over 975,000 ordinary shares in the Company in two tranches on 15 October 2013 and13 November 2013.

 

For further information please contact:

 

Plant Health Care plc

Dr Christopher Richards, Chairman

Tel: +44 (0) 20 7250 1446

Paul Schmidt, Chief Executive Officer

Tel: +1-412-826-5488

 

Nomura Code Securities

Dr Christopher Golden / Juliet Thompson

Tel: +44 (0) 20 7776 1200

 

Powerscourt

Nick Dibden / Sophie Moate

 

Tel: +44 (0)20 7250 1446

nick.dibden@powerscourt-group.com

sophie.moate@powerscourt-group.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABELLFXKFEBBB
Date   Source Headline
12th Nov 20193:56 pmRNSHolding(s) in Company
6th Nov 201912:57 pmRNSInvestment in Company by Ospraie Ag Science LLC
30th Oct 20197:00 amRNSAppointment of new Board Directors
3rd Oct 20192:50 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim Report ended 30 June 2019
9th Sep 20197:00 amRNSPilot production of PREtec peptides
19th Aug 20197:00 amRNSBlock listing Interim Review
15th Aug 20197:00 amRNSProgress with PREtec field trials in Brazil
5th Aug 20195:18 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSNew Distribution Agreement with Wilbur-Ellis
12th Jun 201911:05 amRNSResult of AGM
30th Apr 20194:19 pmRNSAnnual Report & Accounts and AGM Notice Published
10th Apr 20197:00 amRNSResults for the year ended 31 December 2018
27th Mar 20193:41 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSNew Technology Update
19th Feb 20197:00 amRNSBlock listing Interim Review
29th Jan 20197:00 amRNSTrading Statement
24th Jan 20195:58 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSTrading Statement
28th Nov 20187:00 amRNSNew Technology Update
21st Nov 20187:00 amRNSPlant Health Care ProAct® Wins Top Industry Award
19th Nov 20187:00 amRNSPlant Health Care to present at Mello London
14th Nov 20187:00 amRNSPositive Developments with Harpin
8th Nov 20187:00 amRNSChange of Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
18th Sep 20187:00 amRNSInterim Report ended 30 June 2018
12th Sep 20187:00 amRNSUS Announces Harpin aß Product Launch in Corn
20th Aug 20187:00 amRNSBlock listing Interim Review
30th Jul 20187:00 amRNSUpdate on sugarcane in Brazil
16th Jul 20187:00 amRNSTrading Statement
6th Jun 20182:39 pmRNSHolding(s) in Company
6th Jun 201811:14 amRNSResult of AGM
30th May 20187:00 amRNSGrant of Options
4th May 20185:59 pmRNSHolding(s) in Company
30th Apr 20183:11 pmRNSPublication of Annual Report and Notice of AGM
10th Apr 20187:00 amRNSResults for the year ended 31 December 2017
8th Mar 20187:00 amRNSBlock listing Interim Review
7th Mar 20183:07 pmRNSHolding(s) in Company
7th Mar 20183:06 pmRNSHolding(s) in Company
7th Mar 20183:02 pmRNSHolding(s) in Company
2nd Mar 20185:48 pmRNSHolding(s) in Company
27th Feb 20184:12 pmRNSResult of Placing and Subscription
27th Feb 20187:00 amRNSProposed Placing and Subscription
24th Jan 20187:00 amRNSTrading Statement
12th Dec 20177:00 amRNSNew Technology Update
8th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20174:40 pmRNSSecond Price Monitoring Extn
6th Dec 20174:35 pmRNSPrice Monitoring Extension
18th Sep 20177:00 amRNSHalf-year Report
21st Aug 20177:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.